Dipna Pharmachem Ltd — Important, 30-08-2025: Company Update

Dipna Pharmachem has received in-principle approval from BSE to issue 7.66 crore warrants. These warrants are convertible into an equal number of equity shares, each with a face value of Rs. 10, at a price of Rs. 13.05 per share. This approval allows the company to proceed with a preferential issue to both promoters and non-promoters. This move is a crucial step for the company to raise capital, enhancing its financial flexibility and supporting future business operations. Investors should note this as a potential capital infusion for growth.